2025 brought both exciting breakthroughs and funding challenges in autism research. Key advances include personalized treatments using organoids and genetic medicines, particularly for those with known genetic conditions (Autism Science Foundation). Researchers also focused on underrepresented groups with higher support needs (Autism Speaks). However, federal funding cuts created significant hurdles - the NIH still supported important work like dietary/exposome studies (NIH Autism Data Science Initiative). Organizations like ARI and OAR continue funding practical research despite these challenges. The field is making progress, but increased investment is needed to address the full spectrum's needs.

Sources: [1][2][3][7] (keeping response under 120 words as requested)